BlackRock Fund Advisors’s Kite Pharma, Inc. KITE Stock Holding History

BlackRock Fund Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$89.4M	Buy	1,994,083 +242,867	+14%	+$11.9M	0.02%	1286
2016 Q3	$97.8M	Buy	1,751,216 +94,421	+6%	+$5.26M	0.02%	1084
2016 Q2	$82.8M	Buy	1,656,795 +148,580	+10%	+$7.3M	0.02%	1125
2016 Q1	$69.2M	Buy	1,508,215 +192,512	+15%	+$9.33M	0.02%	1231
2015 Q4	$81.1M	Sell	1,315,703 -32,734	-2%	-$2.3M	0.02%	1127
2015 Q3	$75.1M	Buy	1,348,437 +101,305	+8%	+$6.37M	0.02%	1130
2015 Q2	$76M	Buy	1,247,132 +526,570	+73%	+$30M	0.02%	1227
2015 Q1	$41.6M	Buy	720,562 +33,499	+5%	+$2.25M	0.01%	1631
2014 Q4	$39.6M	Buy	687,063 +495,356	+258%	+$20.9M	0.01%	1616
2014 Q3	$5.46M	Buy	+191,707	New	+$4.74M	﹤0.01%	2695

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's KITE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Kite Pharma, Inc. (KITE) stake by 14% in Q4 2016, buying an estimated $11.9M and bringing the position to 1,994,083 shares worth $89.4M. The position accounts for 0.02% of the portfolio, ranked #1286.

BlackRock Fund Advisors first reported a position in KITE in Q3 2014 and has held it in 10 quarters since. The position peaked at $97.8M in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

BlackRock Fund Advisors held 1,994,083 shares of Kite Pharma, Inc. worth $89.4M as of Q4 2016.
BlackRock Fund Advisors bought 242,867 Kite Pharma, Inc. shares in Q4 2016, an estimated $11.9M.
Kite Pharma, Inc. made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1286 holding.
BlackRock Fund Advisors first reported a position in Kite Pharma, Inc. in Q3 2014 and has held it in 10 quarters since.
BlackRock Fund Advisors's Kite Pharma, Inc. position peaked at $97.8M in Q3 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.